Say something

Parabolic Drugs adds 15 percent capacity to its Cephalosporin facility

Parabolic Drugs Ltd., a vertically integrated API manufacturer and exporter in India, today announced the commissioning of eighth manufacturing plant at its European GMP Accredited Derabassi facility – fully dedicated for the manufacturing of latest generation Cephalosporin, both in Oral and Sterile forms. Highlights of the new Manufacturing Plant


post_id:
uld_count:

Cookie not set


Value 1: 0

Value 2: 10

Follow and connect with us on

Related Research


whatsapp--v1